Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma.

Ternant, David

Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma. [electronic resource] - British journal of clinical pharmacology Oct 2009 - 561-73 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2125

10.1111/j.1365-2125.2009.03494.x doi


Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cyclophosphamide--administration & dosage
Disease-Free Survival
Doxorubicin
Humans
Lymphoma, Follicular--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Middle Aged
Models, Theoretical
Prednisone--administration & dosage
Randomized Controlled Trials as Topic
Receptors, IgG
Rituximab
Vincristine--administration & dosage
Young Adult